DBD Diebold Nixdorf Incorporated Common stock

NYSE · Technology · SEC EDGAR'da Görüntüle ↗

$83,16

Fiyat · Tem 2, 2026

Temel veriler itibarıyla Nis 30, 2026

52 Haftlık Aralık

$54–$89

83% of range

Analist Derecelendirmesi

DBD Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

Fiyat

$83.16

Piyasa Değeri

$2.40B

P/E (TTM)

26.7

EPS (TTM)

$2.54

Gelir (TTM)

$3.81B

Temettü Verimi

0.32%

ROE

9.3%

D/E Borç/Özsermaye

0.9

52 Haftlık Aralık

$54 – $89

DBD Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Gelir ve Net Gelir $3.81B

2018-12-31 → 2025-12-31

Hisse Başına Kâr $2.54

2018-12-31 → 2025-12-31

Serbest Nakit Akışı —

Marjlar 2.5%

2018-12-31 → 2025-12-31

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik

5 Yıllık trend

DBD

Akran Ortalaması

P/E (TTM)

26.7

22.9

P/S (TTM) (F/S (TTM))

0.6

2.1

P/B (F/D)

2.2

4.6

EV / EBITDA

8.0

—

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik

5 Yıllık trend

DBD

Akran Ortalaması

Gross Margin (Brüt Kar Marjı)

25.3%

34.0%

Operating Margin (Faaliyet Kâr Marjı)

6.4%

—

Net Profit Margin (Net Kâr Marjı)

2.5%

11.1%

ROA

2.6%

6.5%

ROE

9.3%

14.7%

ROIC

9.6%

—

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik

5 Yıllık trend

DBD

Akran Ortalaması

Debt / Equity (Borç / Öz Sermaye)

0.9

105.2

Current Ratio (Cari Oran)

1.3

Quick Ratio (Cari Oran)

0.7

—

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik

5 Yıllık trend

DBD

Akran Ortalaması

Revenue YoY (Gelir Yıllık Bazda)

1.5%

—

Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)

3.2%

—

Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)

-0.50%

—

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik

5 Yıllık trend

DBD

Akran Ortalaması

EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))

$2.54

—

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik

5 Yıllık trend

DBD

Akran Ortalaması

Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR

Temettü Verimi

0.32%

Temettü Ödeme Oranı

—

5 Yıllık Temettü CAGR

—

DBD Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

AL 7 analist

Güçlü Al 2 28,6%
Al 4 57,1%
Tut 1 14,3%
Sat 0 0,0%
Güçlü Sat 0 0,0%

12 Aylık Fiyat Hedefi

3 analist · 2026-06-29

Medyan $100.00

Ortalama $98.33

← Tüm hedeflerin altında $83.16

Düşük $95.00

Yüksek $100.00

Medyan hedef $100.00 +20,3%

Ortalama hedef $98.33 +18,2%

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Ort. Sürpriz

0.39%

Sonraki Rapor

Ağu 04, 2026

Dönem	EPS Gerçek	EPS Tahmin	Sürpriz
31 Mart 2026	$0.67	$0.62	0.05%
31 Aralık 2025	$2.75	$1.64	1.1%
30 Eylül 2025	$1.38	$0.94	0.44%
30 Haziran 2025	$0.94	$0.59	0.35%
31 Mart 2025	$0.37	$0.36	0.01%

Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
DBD	$2.40B	26.7	1.5%	2.5%	9.3%	25.3%
P	—	—	15.6%	5.1%	13.6%	70.4%
HPQ	$25.48B	10.4	3.2%	4.6%	-311.8%	20.6%
IONQ	$16.27B	-24.7	201.8%	-392.6%	-24.4%	—
SMCI	$29.12B	29.2	46.6%	4.8%	17.9%	11.1%
GPGI	—	-15.7	-85.8%	-227.3%	-198.9%	48.0%
INFQ	—	—	—	—	172.0%	—
QUBT	$2.30B	-93.3	82.8%	-2738.1%	-1.9%	9.8%
CRSR	$633M	-49.5	11.9%	-1.1%	-2.6%	28.9%
KODK	$824M	-4.8	2.5%	-12.0%	-22.4%	21.7%
AAPL	$3.77T	34.2	6.4%	26.9%	159.4%	46.9%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Gelir Tablosu 17

DBD için Yıllık Gelir Tablosu verileri
Metrik	2025	2024	2023	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	$3.81B	$3.75B	·	·	$3.46B	$3.91B	$3.90B	$4.41B	$4.58B	$4.61B	$3.32B	$2.42B
Cost of Revenue	$2.84B	$2.83B	·	·	$2.70B	$2.86B	$2.87B	$3.34B	$3.68B	$3.61B	$2.60B	$1.77B
Gross Profit	$961M	$920M	·	·	$757M	$1.04B	$1.03B	$1.07B	$899M	$1000M	$712M	$652M
R&D Expense	$87M	$94M	·	·	$121M	$126M	$133M	$147M	$157M	$156M	$110M	$87M
SG&A Expense	$632M	$644M	·	·	$742M	$776M	$859M	$909M	$894M	$934M	$761M	$488M
Operating Expenses	$719M	$738M	·	·	$969M	$906M	$-1.01B	$-1.09B	$1.22B	$1.09B	$882M	$593M
Operating Income	$242M	$182M	·	·	$-212M	$137M	$24M	$-27M	$-326M	$-94M	$-170M	$59M
Interest Expense	·	·	·	·	$199M	$195M	$267M	$203M	$155M	$117M	$101M	$32M
Other Non-op	$4M	$2M	·	·	$2M	$3M	$7M	$-4M	$-4M	$2M	$3M	$4M
Pretax Income	$125M	$47M	·	·	$-439M	$-51M	$-270M	$-229M	$-478M	$-192M	$-249M	$46M
Income Tax	$24M	$64M	·	·	$149M	$28M	$-1M	$117M	$37M	$28M	$-69M	$-14M
Net Income	$95M	$-16M	·	·	$-581M	$-79M	$-269M	$-341M	$-531M	$-242M	$-42M	$74M
EPS (Basic)	$2.57	$-0.44	·	·	$-7.36	$-1.01	·	·	$-7.48	$-3.20	$-0.60	$1.13
EPS (Diluted)	$2.54	$-0.44	·	·	$-7.36	$-1.01	$-3.47	·	$-7.48	$-3.20	$-0.60	$1.12
Shares (Basic)	36,800,000	37,600,000	·	·	79,000,000	78,300,000	·	·	76,000,000	75,500,000	69,100,000	64,900,000
Shares (Diluted)	37,200,000	37,600,000	·	·	79,000,000	78,300,000	77,600,000	76,700,000	76,000,000	75,500,000	69,100,000	65,600,000
EBITDA	$370M	$222M	·	·	$-212M	$137M	$24M	$200M	$-104M	$169M	$-25M	$123M

Bilanço 30

DBD için Yıllık Bilanço verileri
Metrik	2025	2024	2023	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	$369M	$296M	$550M	$391M	$307M	·	·	$281M	$458M	$535M	$653M	$314M
Short-term Investments	$29M	$17M	$13M	$14M	$25M	$34M	$37M	$10M	$34M	$81M	$64M	$40M
Receivables	$609M	$588M	$722M	$624M	$612M	$595M	$647M	$619M	$737M	$828M	$836M	$414M
Inventory	$521M	$528M	$590M	$746M	$588M	$544M	$498M	$466M	$610M	$714M	$738M	$369M
Prepaid Expense	$51M	$46M	$44M	$46M	$50M	$48M	$59M	$51M	$57M	$66M	$61M	$24M
Other Current Assets	$189M	$177M	$193M	$248M	$168M	$203M	$227M	$231M	$225M	$248M	$183M	$148M
Current Assets	$1.79B	$1.67B	$2.15B	$2.14B	$1.77B	$1.89B	$1.86B	$1.89B	$2.20B	$2.48B	$2.62B	$1.64B
PP&E (Net)	·	$128M	$159M	$166M	$121M	$138M	$178M	$232M	$304M	$364M	$387M	$175M
PP&E (Gross)	$226M	$170M	$173M	$166M	$600M	$632M	$714M	$758M	$798M	$783M	$864M	$609M
Accum. Depreciation	$81M	$42M	$14M	$0	$479M	$494M	$536M	$527M	$494M	$419M	$477M	$434M
Goodwill	$642M	$586M	$612M	$621M	$702M	$744M	$800M	$764M	$798M	$1.05B	$998M	$162M
Intangibles	$792M	$779M	$891M	·	$258M	$348M	$449M	$502M	$625M	$774M	$773M	$68M
Other Non-current Assets	$242M	$195M	$169M	$266M	$97M	$132M	$122M	$91M	$86M	$96M	$63M	$8M
Total Assets	$3.85B	$3.54B	$4.16B	$4.18B	$3.06B	$3.51B	$3.66B	$3.79B	$4.28B	$5.22B	$5.27B	$2.24B
Accounts Payable	$431M	$460M	$529M	$461M	$612M	$706M	$500M	$472M	$510M	$562M	$560M	$282M
Short-term Debt	·	$200.0K	$300.0K	$5M	$24M	$47M	$11M	$32M	$50M	$67M	$107M	$32M
Current Liabilities	$1.37B	$1.27B	$1.42B	$1.41B	$1.60B	$1.75B	$1.65B	$1.60B	$1.57B	$1.80B	$1.82B	$956M
Capital Leases	$92M	$76M	$65M	·	$77M	$103M	$93M	$106M	$0	·	·	·
Deferred Tax	$201M	$177M	$205M	$238M	$97M	$106M	$103M	$134M	$154M	$287M	$301M	$2M
Other Non-current Liabilities	$118M	$110M	$27M	$124M	$32M	$36M	$60M	$89M	$87M	$111M	$88M	$29M
Total Liabilities	$2.75B	$2.61B	$3.08B	$3.13B	$4.44B	·	·	·	·	·	·	·
Long-term Debt	$938M	$927M	$1.25B	·	$2.56B	·	·	·	·	·	·	·
Total Debt	$938M	$400.0K	$300.0K	·	$24M	$47M	$11M	$32M	$50M	$67M	$107M	$32M
Common Stock	$400.0K	$400.0K	$400.0K	$400.0K	$120M	$118M	$117M	$115M	$114M	$113M	$112M	$100M
Retained Earnings	$92M	$-1M	$17M	$0	$-1.41B	$-822M	$-742M	$-472M	$-131M	$374M	$663M	$760M
Treasury Stock	$131M	$0	$0	$0	$586M	$582M	$577M	$572M	$570M	$567M	$562M	$560M
AOCI	$78M	$-118M	$8M	$0	$-360M	$-378M	$-413M	$-375M	$-304M	$-196M	$-341M	$-318M
Stockholders' Equity	$1.10B	$930M	$1.06B	$1.04B	$-1.38B	$-845M	$-827M	$-530M	$-150M	$446M	$589M	$412M
Liabilities + Equity	$3.85B	$3.54B	$4.16B	$4.18B	$3.06B	$3.51B	$3.66B	$3.79B	$4.28B	$5.22B	$5.27B	$2.24B
Shares Outstanding	35,384,690	37,576,678	37,566,678	·	79,103,450	78,352,333	77,678,984	76,813,013	76,174,025	75,558,544	75,144,784	65,001,602

Nakit Akışı 14

DBD için Yıllık Nakit Akışı verileri
Metrik	2025	2024	2023	2023	2022	2021	2020	2019	2018	2017	2016	2015
D&A	$128M	$132M	·	·	$56M	$71M	·	$226M	$248M	$252M	$135M	$64M
Stock-based Comp	$12M	$10M	·	·	$13M	$14M	$15M	$24M	$37M	$34M	$22M	$12M
Deferred Tax	$-48M	$-8M	·	·	$93M	$-13M	$-20M	$78M	$-14M	$-40M	$-44M	$-49M
Amort. of Intangibles	·	·	·	·	·	·	·	$144M	$153M	$159M	·	·
Restructuring	$94M	$106M	·	·	$124M	$28M	$82M	$50M	$65M	$49M	$59M	$21M
Other Non-cash	$115M	$124M	·	·	·	·	·	$149M	$184M	$24M	$-52M	$-64M
Operating Cash Flow	$301M	$149M	·	·	$-388M	$123M	$18M	$136M	$-104M	$37M	$29M	$37M
Investing Cash Flow	$-98M	$-46M	·	·	$-24M	$-49M	$-83M	$-7M	$34M	$-121M	$-561M	$-65M
Stock Repurchased	$131M	$0	·	·	$8M	$8M	$7M	$2M	$3M	$5M	$2M	$3M
Net Stock Activity	$-131M	$-6M	·	·	$-8M	$-8M	$-7M	$-2M	$-3M	$-5M	$-2M	$-3M
Dividends Paid	·	·	·	·	·	·	$0	$0	$8M	$31M	$65M	$76M
Financing Cash Flow	$-144M	$-366M	·	·	$350M	$-4M	$17M	$-216M	$11M	$-64M	$881M	$42M
Net Change in Cash	$76M	$-281M	·	·	$-70M	$65M	$-51M	$-88M	$-78M	$-110M	$341M	$-10M
Taxes Paid	$57M	$56M	·	·	$33M	$42M	$44M	$42M	$65M	$78M	$84M	$65M

Kârlılık 8

DBD için Yıllık Kârlılık verileri
Metrik	2025	2024	2023	2023	2022	2021	2020	2019	2018	2017	2016	2015
Gross Margin	25.3%	24.5%	·	·	21.9%	26.7%	26.5%	24.2%	19.5%	21.9%	21.8%	27.0%
Operating Margin	6.4%	4.9%	·	·	-6.1%	3.5%	0.62%	-0.60%	-7.9%	-1.8%	-4.8%	2.4%
Net Margin	2.5%	-0.44%	·	·	-16.8%	-2.0%	-6.9%	-7.7%	-12.4%	-5.1%	-1.0%	3.0%
Pretax Margin	3.3%	1.3%	·	·	-12.7%	-1.3%	-6.9%	-5.2%	-11.3%	-3.8%	-7.2%	1.9%
EBITDA Margin	9.7%	5.9%	·	·	-6.1%	3.5%	0.62%	4.5%	-2.3%	3.7%	-0.75%	5.1%
ROA	2.6%	-0.43%	·	·	-17.7%	-2.2%	-7.2%	-8.5%	-11.9%	-4.4%	-0.88%	3.2%
ROE	9.3%	-1.7%	·	·	52.2%	9.4%	39.6%	100.4%	-3345.3%	-44.9%	-5.0%	18.1%
ROIC	9.6%	-7.0%	·	·	20.9%	-26.6%	-2.9%	8.1%	284.2%	-18.2%	-16.4%	17.1%

Likidite ve Solventlik 5

DBD için Yıllık Likidite ve Solventlik verileri
Metrik	2025	2024	2023	2023	2022	2021	2020	2019	2018	2017	2016	2015
Current Ratio	1.3	1.3	1.5	·	1.1	1.1	1.1	1.2	1.4	1.4	1.4	1.7
Quick Ratio	0.7	0.7	0.9	·	0.4	0.3	0.4	0.4	0.5	0.8	0.9	0.8
Debt / Equity	0.9	0.0	0.0	·	-0.0	-0.1	-0.0	-0.1	-0.3	0.1	0.2	0.1
LT Debt / Equity	0.9	·	·	·	·	·	·	·	·	·	·	·
Interest Coverage	·	·	·	·	-1.1	0.7	0.1	-0.1	-2.3	-0.7	-1.6	1.8

Verimlilik 3

DBD için Yıllık Verimlilik verileri
Metrik	2025	2024	2023	2023	2022	2021	2020	2019	2018	2017	2016	2015
Asset Turnover	1.0	1.0	·	·	1.1	1.1	1.0	1.1	1.0	0.9	0.9	1.1
Inventory Turnover	5.4	5.1	·	·	4.8	5.5	5.9	6.2	5.6	4.9	4.7	4.8
Receivables Turnover	6.4	5.7	·	·	5.7	6.3	6.2	6.5	5.9	5.5	5.3	5.9

Hisse Başına 6

DBD için Yıllık Hisse Başına verileri
Metrik	2025	2024	2023	2023	2022	2021	2020	2019	2018	2017	2016	2015
Book Value / Share	$31.08	$24.74	$28.32	·	$-17.46	$-10.79	$-10.65	$-6.90	$-2.45	$6.22	$7.87	$6.34
Revenue / Share	$102.30	$99.76	·	·	$43.81	$49.87	$50.29	$57.48	$60.24	$61.05	$47.99	$36.88
Cash Flow / Share	$8.08	$3.97	·	·	$-4.91	$1.57	$0.23	$1.77	$-1.37	$0.49	$0.41	$0.56
Cash / Share	$10.43	$7.88	$14.65	·	·	·	·	·	·	$7.08	$8.69	$4.82
Dividend Paid / Share	·	·	·	·	·	·	$0	$0	$0	$0	$1	$1
EPS (TTM)	$2.54	$-0.44	·	·	$-7.36	$-1.01	$-3.47	$-4.48	$-7.48	$-3.20	$-0.60	$1.12

Büyüme Oranları 3

DBD için Yıllık Büyüme Oranları verileri
Metrik	2025	2024	2023	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue YoY	1.5%	·	·	·	-11.4%	0.07%	·	·	·	·	·	·
Revenue CAGR 3Y	3.2%	-1.3%	·	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	-0.50%	·	·	·	·	·	·	·	·	·	·	·

Değerleme (TTM) 14

DBD için Yıllık Değerleme (TTM) verileri
Metrik	2025	2024	2023	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue TTM	$3.81B	$3.75B	$3.44B	·	$3.46B	$3.91B	$3.90B	$4.41B	$4.58B	$4.61B	$3.32B	$2.42B
Net Income TTM	$95M	$-16M	$-1.04B	·	$-581M	$-79M	$-269M	$-341M	$-531M	$-242M	$-42M	$74M
Market Cap	$2.40B	$1.62B	$1.09B	·	·	·	·	·	·	·	·	·
Enterprise Value	$2.94B	$1.30B	$524M	·	·	·	·	·	·	·	·	·
P/E	26.7	-97.8	·	·	·	·	·	·	·	·	·	·
P/S	0.6	0.4	0.3	·	·	·	·	·	·	·	·	·
P/B	2.2	1.7	1.0	·	·	·	·	·	·	·	·	·
P / Cash Flow	8.0	10.8	·	·	·	·	·	·	·	·	·	·
EV / EBITDA	8.0	5.9	·	·	·	·	·	·	·	·	·	·
EV / Revenue	0.8	0.3	0.2	·	·	·	·	·	·	·	·	·
Dividend Yield	0.32%	0.48%	0.71%	·	·	·	·	·	·	·	·	·
Earnings Yield	3.7%	-1.0%	·	·	·	·	·	·	·	·	·	·
Payout Ratio	·	·	·	·	·	·	0.00%	0.00%	-1.4%	-13.1%	-195.8%	102.6%
Annual Payout	$8M	$8M	$8M	·	$8M	$8M	$0	$0	$8M	$31M	$65M	$76M

Gelir Tablosu 17

DBD için Çeyreklik Gelir Tablosu verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Revenue	$892M	$1.10B	$945M	$915M	$841M	$989M	$927M	$940M	$895M	·	$922M	$858M	$969M	$810M	$852M	$830M
Cost of Revenue	$679M	$824M	$700M	$681M	$639M	$757M	$690M	$696M	$687M	·	$697M	$649M	$751M	$617M	$691M	$644M
Gross Profit	$213M	$280M	$245M	$234M	$202M	$232M	$237M	$243M	$209M	·	$225M	$209M	$217M	$194M	$161M	$185M
R&D Expense	$22M	$21M	$20M	$22M	$23M	$24M	$23M	$22M	$24M	·	$25M	$26M	$29M	$27M	$33M	$32M
SG&A Expense	$157M	$176M	$151M	$154M	$152M	$165M	$165M	$152M	$162M	·	$201M	$184M	$184M	$163M	$214M	$181M
Operating Expenses	$180M	$197M	$171M	$178M	$173M	$190M	$190M	$172M	$185M	·	$229M	$211M	$260M	$188M	$252M	$269M
Operating Income	$33M	$82M	$74M	$56M	$30M	$41M	$46M	$71M	$24M	·	$-4M	$-2M	$-42M	$6M	$-92M	$-83M
Interest Expense	·	·	·	·	·	·	·	·	$44M	·	$70M	$82M	·	$51M	$50M	$48M
Other Non-op	$2M	$900.0K	$-900.0K	$2M	$2M	$-4M	$2M	$3M	$1M	·	$4M	$3M	$5M	$-10M	$5M	$3M
Pretax Income	$12M	$63M	$52M	$17M	$-7M	$6M	$10M	$45M	$-14M	·	$-702M	$-90M	$-127M	$-46M	$-133M	$-132M
Income Tax	$6M	$12M	$10M	$5M	$-2M	$6M	$30M	$32M	$-3M	·	$-25M	$21M	$30M	$4M	$64M	$51M
Net Income	$5M	$50M	$41M	$12M	$-8M	$6M	$-22M	$15M	$-15M	·	$-677M	$-111M	$-149M	$-50M	$-199M	$-183M
EPS (Basic)	$0.14	$1.33	$1.13	$0.33	$-0.22	$0.15	$-0.60	$0.40	$-0.39	·	$-8.46	$-1.40	$-1.88	$-0.63	$-2.52	$-2.33
EPS (Diluted)	$0.14	$1.32	$1.11	$0.33	$-0.22	$0.15	$-0.60	$0.40	$-0.39	·	$-8.46	$-1.40	$-1.88	$-0.63	·	·
Shares (Basic)	35,100,000	-74,500,000	36,500,000	37,200,000	37,600,000	-75,200,000	37,600,000	37,600,000	37,600,000	·	80,000,000	79,300,000	-157,800,000	79,100,000	79,000,000	78,700,000
Shares (Diluted)	35,700,000	-74,900,000	37,000,000	37,500,000	37,600,000	-75,300,000	37,600,000	37,700,000	37,600,000	·	80,000,000	79,300,000	100,000	79,100,000	·	·
EBITDA	$64M	·	$74M	$56M	$42M	·	$46M	$71M	$33M	·	$-4M	$10M	·	$6M	$-92M	$-69M

Bilanço 30

DBD için Çeyreklik Bilanço verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Cash & Equivalents	$359M	$369M	$246M	$279M	$306M	$296M	$251M	$277M	$282M	$376M	·	·	$307M	·	·	·
Short-term Investments	$0	$29M	$17M	$15M	$8M	$17M	$11M	$9M	$19M	$17M	$11M	$17M	·	$15M	$31M	$42M
Receivables	$597M	$609M	$580M	$599M	$603M	$588M	$665M	$650M	$661M	$704M	$656M	$627M	$612M	$538M	$563M	$550M
Inventory	$553M	$521M	$600M	$574M	$553M	$528M	$641M	$633M	$636M	$666M	$648M	$640M	·	$666M	$642M	$621M
Prepaid Expense	$31M	$51M	$40M	$39M	$43M	$46M	$40M	$34M	$46M	$47M	$47M	$53M	·	$47M	$48M	$50M
Other Current Assets	$245M	$189M	$216M	$208M	$195M	$177M	$207M	$220M	$223M	$207M	$224M	$220M	·	$225M	$252M	$234M
Current Assets	$1.80B	$1.79B	$1.72B	$1.74B	$1.73B	$1.67B	$1.90B	$1.91B	$1.97B	$2.08B	$2.14B	$1.81B	·	$1.68B	$1.85B	$1.78B
PP&E (Net)	·	·	·	·	$131M	·	$144M	$147M	$153M	$159M	$119M	$120M	·	$112M	$117M	$132M
PP&E (Gross)	$225M	·	$205M	$198M	·	·	·	·	·	$168M	·	·	·	·	·	·
Accum. Depreciation	$84M	$81M	$69M	$61M	$51M	$42M	$46M	$35M	$28M	$9M	$498M	$490M	·	$453M	$467M	$501M
Goodwill	$632M	$642M	$642M	$641M	$604M	$586M	$620M	$602M	$606M	$597M	$713M	$702M	$702M	$650M	$689M	$732M
Intangibles	$765M	$792M	$808M	$816M	$784M	$779M	$846M	$833M	$858M	$884M	$227M	$245M	·	$254M	$290M	$324M
Other Non-current Assets	$237M	$242M	$213M	$210M	$178M	$195M	$312M	$291M	$285M	$257M	$248M	$252M	·	$250M	$277M	$288M
Total Assets	$3.83B	$3.85B	$3.72B	$3.74B	$3.63B	$3.54B	$3.90B	$3.85B	$3.94B	$4.02B	$3.41B	$3.09B	·	$2.91B	$3.18B	$3.32B
Accounts Payable	$483M	$431M	$462M	$431M	$450M	$460M	$479M	$490M	$537M	$529M	$504M	$636M	·	$624M	$718M	$624M
Short-term Debt	·	·	·	·	·	·	$800.0K	$500.0K	$500.0K	$5M	$1.25B	$84M	·	$2.44B	$11M	$10M
Current Liabilities	$1.40B	$1.37B	$1.26B	$1.27B	$1.28B	$1.27B	$1.31B	$1.34B	$1.42B	$1.41B	$3.09B	$1.74B	·	$3.90B	$1.66B	$1.66B
Capital Leases	$99M	$92M	$85M	$83M	$79M	$76M	·	·	·	$66M	·	·	·	·	·	·
Deferred Tax	$197M	$201M	$161M	$185M	$180M	$177M	$210M	$208M	$195M	$166M	$67M	$101M	·	$115M	$136M	$106M
Other Non-current Liabilities	$147M	$118M	$125M	$117M	$35M	$110M	$96M	$84M	$86M	$97M	$96M	$107M	·	$120M	$133M	$136M
Total Liabilities	$2.80B	$2.75B	$2.61B	$2.63B	$2.63B	$2.61B	$2.83B	$2.84B	$2.92B	$3.03B	$3.30B	·	·	·	·	·
Long-term Debt	$939M	$938M	$934M	$931M	$929M	$927M	$1.07B	$1.07B	$1.07B	$1.26B	$2.17B	$2.6K	·	·	·	·
Total Debt	$939M	·	$934M	$931M	$929M	·	$800.0K	$500.0K	$500.0K	$5M	$1.25B	$84M	·	$2.44B	$11M	$10M
Common Stock	$400.0K	$400.0K	$400.0K	$400.0K	$400.0K	$400.0K	$400.0K	$400.0K	$400.0K	$400.0K	$121M	$121M	·	$120M	$120M	$120M
Retained Earnings	$97M	$92M	$44M	$3M	$-9M	$-1M	$-5M	$17M	$2M	$-26M	$-2.19B	$-1.52B	·	$-1.25B	$-1.20B	$-1.01B
Treasury Stock	$191M	$131M	$80M	$40M	$10M	$0	·	·	·	$0	$586M	$586M	·	$586M	$585M	$585M
AOCI	$53M	$78M	$85M	$79M	$-49M	$-118M	$25M	$-64M	$-30M	$-36M	$-328M	$-354M	·	$-437M	$-412M	$-365M
Stockholders' Equity	$1.02B	$1.10B	$1.11B	$1.10B	$984M	$930M	$1.07B	$997M	$1.01B	$977M	$-2.14B	$-1.49B	·	$-1.33B	$-1.26B	$-1.02B
Liabilities + Equity	$3.83B	$3.85B	$3.72B	$3.74B	$3.63B	$3.54B	$3.90B	$3.85B	$3.94B	$4.02B	$3.41B	$3.09B	·	$2.91B	$3.18B	$3.32B
Shares Outstanding	34,751,349	35,384,690	36,202,209	36,859,610	37,463,960	37,576,678	37,566,678	37,566,668	37,566,668	37,566,668	80,031,494	79,609,121	·	79,065,985	79,043,588	78,927,653

Nakit Akışı 12

DBD için Çeyreklik Nakit Akışı verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
D&A	$31M	$31M	$32M	$53M	$34M	$38M	$79M	$54M	$9M	·	$13M	$12M	$14M	$13M	$15M	$14M
Stock-based Comp	$3M	$3M	$3M	$3M	$3M	$2M	$3M	$3M	$2M	·	$800.0K	$1M	$4M	$3M	$5M	$2M
Amort. of Intangibles	·	·	·	·	·	·	·	·	$24M	·	·	$18M	·	·	·	·
Restructuring	$24M	$45M	$13M	$16M	$20M	$27M	$32M	$11M	$37M	·	$19M	$15M	$25M	$21M	$78M	$0
Other Non-cash	$-8M	·	·	·	$9M	·	·	·	$-20M	·	·	$2M	·	·	·	$-59M
Operating Cash Flow	$32M	$218M	$37M	$30M	$16M	$196M	$-16M	$-8M	$-24M	·	$-242M	$-96M	$95M	$-176M	$-80M	$-226M
Investing Cash Flow	$20M	$-39M	$-26M	$-33M	$0	$-17M	$-12M	$2M	$-18M	·	$-5M	$-2M	$-23M	$6M	$-1M	$-6M
Stock Repurchased	$60M	$51M	$40M	$30M	$10M	$0	$-3M	$-2M	$0	·	$1M	$2M	$1M	$900.0K	$700.0K	$5M
Net Stock Activity	$-60M	·	·	·	$-10M	·	·	·	$-2M	·	·	$-2M	·	·	·	$-5M
Financing Cash Flow	$-62M	$-56M	$-44M	$-31M	$-13M	$-192M	$-5M	$-12M	$-158M	·	$542M	$21M	$116M	$53M	$115M	$66M
Net Change in Cash	$-14M	$125M	$-33M	$-25M	$9M	$-23M	$-26M	$-28M	$-204M	·	$295M	$-75M	$192M	$-124M	$26M	$-165M
Taxes Paid	$6M	$21M	$8M	$21M	$7M	$16M	$8M	$21M	$11M	·	$14M	$12M	·	·	·	·

Kârlılık 8

DBD için Çeyreklik Kârlılık verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Gross Margin	23.9%	·	25.9%	25.6%	24.1%	·	25.5%	25.9%	23.3%	·	24.4%	24.4%	·	23.9%	18.9%	22.3%
Operating Margin	3.7%	·	7.8%	6.1%	3.5%	·	5.0%	7.5%	2.7%	·	-0.42%	-0.24%	·	0.68%	-10.7%	-10.1%
Net Margin	0.56%	·	4.3%	1.3%	-0.99%	·	-2.4%	1.6%	-1.6%	·	-73.4%	-13.0%	·	-6.2%	-23.4%	-22.1%
Pretax Margin	1.4%	·	5.5%	1.9%	-0.88%	·	1.1%	4.8%	-1.6%	·	-76.1%	-10.5%	·	-5.7%	-15.6%	-15.9%
EBITDA Margin	7.2%	·	7.8%	6.1%	5.0%	·	5.0%	7.5%	3.7%	·	-0.42%	1.1%	·	0.68%	-10.7%	-8.3%
ROA	0.13%	·	1.1%	0.32%	-0.22%	·	-0.57%	0.41%	-0.42%	·	-20.6%	-3.5%	·	-1.5%	-5.9%	-5.4%
ROE	0.50%	·	3.8%	1.2%	-0.83%	·	-2.2%	-2.6%	6.2%	·	39.9%	8.9%	·	4.5%	18.9%	19.6%
ROIC	0.90%	·	2.9%	2.0%	1.1%	·	-9.1%	2.1%	1.8%	·	0.43%	0.18%	·	0.54%	10.9%	11.5%

Likidite ve Solventlik 5

DBD için Çeyreklik Likidite ve Solventlik verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Current Ratio	1.3	·	1.4	1.4	1.3	·	1.4	1.4	1.4	1.5	0.7	1.0	·	0.4	1.1	1.1
Quick Ratio	0.7	·	0.7	0.7	0.7	·	0.7	0.7	0.7	0.8	0.2	0.4	·	0.1	0.4	0.4
Debt / Equity	0.9	·	0.8	0.8	0.9	·	0.0	0.0	0.0	0.0	-0.6	-0.1	·	-1.8	-0.0	-0.0
LT Debt / Equity	0.9	·	0.8	0.8	0.9	·	·	·	·	·	·	·	·	·	·	·
Interest Coverage	·	·	·	·	·	·	·	·	0.5	·	-0.1	-0.0	·	0.1	-1.8	-1.7

Verimlilik 3

DBD için Çeyreklik Verimlilik verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Asset Turnover	0.2	·	0.2	0.2	0.2	·	0.2	0.3	0.3	·	0.3	0.3	·	0.2	0.3	0.2
Inventory Turnover	1.2	·	1.1	1.1	1.1	·	1.1	1.1	1.1	·	1.1	1.0	·	1.0	1.1	1.1
Receivables Turnover	1.5	·	1.5	1.5	1.3	·	1.4	1.4	1.4	·	1.5	1.5	·	1.3	1.4	1.4

Hisse Başına 5

DBD için Çeyreklik Hisse Başına verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Book Value / Share	$29.43	·	$30.58	$29.77	$26.27	·	$28.38	$26.53	$26.97	$26.00	$-26.68	$-18.66	·	$-16.81	$-15.91	$-12.88
Revenue / Share	$24.98	·	$25.55	$24.41	$22.37	·	$24.66	$24.93	$23.81	·	·	·	·	·	·	·
Cash Flow / Share	$0.89	·	·	·	$0.42	·	·	·	$-0.62	·	·	·	·	·	·	·
Cash / Share	$10.32	·	$6.80	$7.57	$8.18	·	$6.68	$7.37	$7.50	$10.01	·	·	·	·	·	·
EPS (TTM)	$1.36	·	$0.62	$-0.09	$-0.81	·	·	·	·	·	·	·	·	·	$-4.48	$-4.48

Değerleme (TTM) 13

DBD için Çeyreklik Değerleme (TTM) verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Revenue TTM	$3.59B	·	$3.63B	$3.62B	$3.60B	·	·	·	·	$3.44B	$3.44B	$3.35B	·	$3.45B	$3.58B	$3.68B
Net Income TTM	$50M	·	$23M	$-4M	$-30M	·	·	·	·	$-1.04B	$-1.04B	$-543M	·	$-434M	$-415M	$-224M
Market Cap	$2.62B	·	$2.06B	$2.04B	$1.64B	·	$1.68B	$1.45B	$1.29B	$712M	·	·	·	·	·	·
Enterprise Value	$3.20B	·	$2.74B	$2.68B	$2.25B	·	$1.42B	$1.16B	$993M	$324M	·	·	·	·	·	·
P/E	55.5	·	92.0	-615.6	-54.0	·	·	·	·	·	·	·	·	·	·	·
P/S	0.7	·	0.6	0.6	0.5	·	·	·	·	0.2	·	·	·	·	·	·
P/B	2.6	·	1.9	1.9	1.7	·	1.6	1.5	1.3	0.7	·	·	·	·	·	·
P / Cash Flow	82.7	·	·	·	104.3	·	·	·	-55.1	·	·	·	·	·	·	·
EV / EBITDA	50.0	·	37.1	47.7	53.6	·	30.5	16.4	30.2	·	·	·	·	·	·	·
EV / Revenue	0.9	·	0.8	0.7	0.6	·	·	·	·	0.1	·	·	·	·	·	·
Dividend Yield	0.29%	·	0.37%	0.38%	0.47%	·	0.46%	0.53%	0.60%	1.1%	·	·	·	·	·	·
Earnings Yield	1.8%	·	1.1%	-0.16%	-1.8%	·	·	·	·	·	·	·	·	·	·	·
Annual Payout	$8M	·	$8M	$8M	$8M	·	$8M	$8M	$8M	$8M	$8M	$8M	·	$8M	$8M	$8M

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Gelir Tablosu

	2025-12-31	2024-12-31	2023-12-31	2023-08-12	2023-08-11
Gelir	$3.81B	$3.75B	—	—	—
Brüt Kâr Marjı %	25.3%	24.5%	—	—	—
Faaliyet Kâr Marjı %	6.4%	4.9%	—	—	—
Net Gelir	$95M	$-16M	—	—	—
Seyreltilmiş Hisse Başı Kâr	$2.54	$-0.44	—	—	—

Bilanço

	2025-12-31	2024-12-31	2023-12-31	2023-08-12	2023-08-11
Borç / Öz Sermaye	0.9	0.0	0.0	—	—
Cari Oran	1.3	1.3	1.5	—	—
Cari Oran	0.7	0.7	0.9	—	—

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

📊

Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

DBD Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

DBD Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

Hareketli ortalamalar ve bindirmeler

Hacim

Osilatörler

Momentum ve eğilim

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR

DBD Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

12 Aylık Fiyat Hedefi

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar